Pricing Log in Create free account

Phio Pharmaceuticals Corp. (PHIO) vs Tempest Therapeutics, Inc. (TPST)

Phio Pharmaceuticals Corp. and Tempest Therapeutics, Inc. are both Biotechnology companies. Phio Pharmaceuticals Corp. and Tempest Therapeutics, Inc. are of similar size ($10.8M and $10.7M). Phio Pharmaceuticals Corp. grew revenue faster over the last twelve months: 79.0% against −53.0%. Across the 10 metrics below, Phio Pharmaceuticals Corp. leads on 8 and Tempest Therapeutics, Inc. on 2.

Valuation

Metric PHIO TPST Biotechnology median
P/E n/m n/m 8.50
P/S 74.31 29.13 9.71
P/B 0.80 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.20 n/m 0.64
EV/Sales (19.55) 33.65 9.21
Earnings yield (148.28%) (690.32%) (33.15%)
Free cash flow yield (120.77%) (224.23%) (25.50%)

Profitability

Metric PHIO TPST Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (113.71%) (931.14%) (56.36%)
Return on assets (100.78%) (237.25%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PHIO TPST Biotechnology median
Revenue growth (TTM) 78.95% (52.98%) 6.02%
EPS growth (last fiscal year) 84.03% 67.55% 30.26%
Revenue growth, 5-year CAGR (21.62%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PHIO TPST Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.39 0.38 4.72
Net debt to EBITDA 2.28 0.29 0.96

Dividend

Metric PHIO TPST Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PHIO TPST Biotechnology median
Market cap 10.75m 10.73m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack